Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

CAS Medical Systems CEO: Following the resignation of Andrew E. Kersey as president, CEO and board member, the maker of non-invasive patient-monitoring devices appoints former Wright Medical Group CEO Thomas M. Patton to the same positions Aug. 27. Patton, who was most recently an advisor to private equity group Ferrer Freeman & Co. and CEO of hematology diagnostics start-up QDx, will help CAS Medical Systems commercialize its Fore-Sight Absolute Oximetry technology
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT029349

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel